New Scenarios in Antidoping Research

Clinical Chemistry

Volumn 49, Issue 12, 2003, Pages 2106-2107

  Lippi, Giuseppe ^a,b   Guidi, Giancesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b OSPEDALE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; DOPING; GENE TRANSFER; GENETIC POLYMORPHISM; HUMAN; LABORATORY TEST; LETTER; PERFORMANCE; SPORT; TRAINING;

DOPING IN SPORTS; GENE THERAPY; HUMANS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RESEARCH; SPORTS;

EID: 0344083629     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.025312     Document Type: Letter

References (8)

1. Lippi G, Guidi G. Doping and sports. Minerva Med 1999;90:345-57.
2. Breidbach A, Catlin DH, Green GA, Tregub I, Truong H, Gorzek J. Detection of recombinant human erythropoietin in urine by isoelectric focusing. Clin Chem 2003;49:901-7.
3. Bidlingmaier M, Wu Z, Strasburger CJ. Doping with growth hormone. J Pediatr Endocrinol Metab 2001;14:1077-83.
4. Catlin DH, Hatton CK. Abuse of recombinant erythropoietins by athletes. In: Molineux G, Foote MA, Elliott S, eds. Erythropoietins and erythropoiesis: molecular, cellular, preclinical, and clinical biology. Basel, Switzerland: Birkhäuser Verlag, 2003:205-27.
5. McCrory P. Super athletes or gene cheats? Br J Sports Med 2003;37:192-3.
6. Williams DA, Nienhuis AW, Hawley RG, Smith FO. Gene therapy 2000. Hematology (Am Soc Hematol Educ) 2000:376-93.
7. Lindpaintner K. Pharmacogenetics and pharmacogenomics in drug discovery and development: an overview. Clin Chem Lab Med 2003;41:398-410.
8. Rankinen T, Perusse L, Rauramaa R, Rivera MA, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes. Med Sci Sports Exerc 2001;33:855-67.